Top Tweets for #ASKAT
SLBG6X & askat - FUNK ETERNO is out now! https://t.co/1imRopJk1A
#FUNKETERNO #Phonk #SLBG6X #askat #Mikoryn #BrazilianPhonk #GymPhonk #BassBoosted
Anadolu’daki Roma İmparatorluğu’nu yakından tanımak isteyenleri 27 Eylül Cumartesi günü saat 14:00’te Cin Ali Müzesi’ne bekliyoruz.
Yerimiz sınırlıdır, lütfen 0312 4268042 numaralı telefondan kayıt yaptırınız.
#cinalivakfı #askat #arkeoloji #ankaraetkinlik
【AskAt】
2023年09月26日「EP4拮抗薬のがん免疫に関するライセンス契約解約に関するお知���せ」
https://t.co/1JUlqAKvqm
Hugely grateful to the #Askat team for all their support - we wouldn't be here without you! #OCTP #pain #cannabinoids
Thank you for your help, assistance and support #AskAt in which #OCTP licensed AskAt’s #cannabinoid CB2 receptor agonist AAT-730 for human use
“I am very happy to announce that OCT starts Phase 1 clinical study”
Mr. Akihiro Furuta, CEO of AskAt
https://t.co/3Li5voMsDx
Thank you for your help, assistance and support #AskAt in which #OCTP licensed AskAt’s #cannabinoid CB2 receptor agonist AAT-730 for human use
“I am very happy to announce that OCT starts Phase 1 clinical study”
Mr. Akihiro Furuta, CEO of AskAt
https://t.co/3Li5voMsDx
Want a deeper dive on our lead programme, about to start its #PhaseI clinical trial? Head to https://t.co/1aak3qpSZ9 for more! #OCTP #cannabinoids #pain
We can announce a strategic re-allocation of our drug development resources and changes to the composition of our #OCTP Board of Directors…
https://t.co/VPI2qFVgXJ
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (3/3) #AskAt #ラクオリア https://t.co/sOyj1R6gBx](https://pbs.twimg.com/media/FZNROvOUEAEHs2F.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (3/3) #AskAt #ラクオリア https://t.co/sOyj1R6gBx](https://pbs.twimg.com/media/FZNROQ6VEAAtALQ.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (3/3) #AskAt #ラクオリア https://t.co/sOyj1R6gBx](https://pbs.twimg.com/media/FZNRNycVUAA-YuR.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (3/3) #AskAt #ラクオリア https://t.co/sOyj1R6gBx](https://pbs.twimg.com/media/FZNRNFwUEAAhIi3.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (2/3) #AskAt #ラクオリア https://t.co/OCyU9kmd5k](https://pbs.twimg.com/media/FZNRI_bUsAII8sO.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (2/3) #AskAt #ラクオリア https://t.co/OCyU9kmd5k](https://pbs.twimg.com/media/FZNRIB2VEAEAN6w.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (2/3) #AskAt #ラクオリア https://t.co/OCyU9kmd5k](https://pbs.twimg.com/media/FZNRHXLVQAETjOL.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (2/3) #AskAt #ラクオリア https://t.co/OCyU9kmd5k](https://pbs.twimg.com/media/FZNRGl3UYAAJQHW.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (1/3) #AskAt #ラクオリア
https://t.co/WIiCTxzKwR https://t.co/Niz0YfeqAV](https://pbs.twimg.com/media/FZNQWIhUcAEm-Kk.jpg)
![ariafloat's tweet photo. CB2 Agonist [OCT461201] (1/3) #AskAt #ラクオリア
https://t.co/WIiCTxzKwR https://t.co/Niz0YfeqAV](https://pbs.twimg.com/media/FZNQVVNUUAAnzIS.jpg)
【AskAt】
2022年07月22日「AAT-076ライセンス契約及び開発サポート契約締結に関するお知らせ」
https://t.co/H6ftZomgJk
#OCTP Announces MSA and Work Order with Simbec Research Limited for Phase 1 Clinical Trials
The trial will be aimed at demonstrating the safety, tolerability, and confirming the value as a potential drug product
https://t.co/qnhxiKqhjZ
ASK ME ANYTHING 💛💛💛 #askat
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers